1. Maher, D. & Raviglione, M.C. The global epidemic of tuberculosis: a World Health Organization perspective. in Tuberculosis and Nontuberculous Mycobacterial Infections, Fourth Edition (ed. Schlossberg, D.) 104–115 (W.B. Saunders Company, Philadelphia, 1999).
2. Waksman, S.A. The Conquest of Tuberculosis (Robert Hale Limited, London, 1964).
3. Ehrlich, P. Address in pathology on chemotherapeutics: scientific principles, methods and results. Lancet 2, 445–451 (1913).
4. McCune, R.M., Tompsett, R. & McDermott, W. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104, 763–801 (1956).
5. Barclay, W.R., Ebert, R.H., Le Roy, G.V., Manthei, R.W. & Roth, L.J. Distribution and excretion of radioactive isoniazid in tuberculosis patients. JAMA 151, 1384–1388 (1953).